Sep 25, 2025 11:00
HSDT - Helius Medical Technologies, Inc. Class A Common Stock (DE)
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
14.65 1.31 (8.94%) | --- | --- | 0.0 (0.0%) | -0.06 (-0.41%) | 1.46 (10.12%) | 0.06 (0.38%) | 0.06 (0.38%) |
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Earnings & Ratios
- Basic EPS:
- -79.73
- Diluted EPS:
- -79.73
- Basic P/E:
- -0.2002
- Diluted P/E:
- -0.2002
- RSI(14) 1m:
- 0.0
- VWAP:
- 15.96
- RVol:
- 0.5094
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
Day | Price increase day | 16.3 +1.65 (+11.26%) | Oct 15 13:56 |
60m | Price increase 60m | 16.3 +0.91 (+5.88%) | Oct 15 13:56 |
10m | Price increase 10m | 16.3 +0.5 (+3.16%) | Oct 15 13:56 |
1m | Price increase 1m | 16.04 +0.22 (+1.39%) | Oct 15 13:54 |
1m | Price increase 1m | 15.91 +0.22 (+1.4%) | Oct 15 13:23 |
Related News
Jun 05, 2025 01:12
Jan 21, 2025 12:00
Oct 18, 2024 12:00
Oct 14, 2024 21:00
Jun 17, 2024 11:00
May 10, 2024 13:00
May 07, 2024 21:30
May 07, 2024 02:15
May 02, 2024 12:15